7-year device lifecycle
Latest hardware components selected guaranteeing supply for a minimum of 7 years.
/ EST. 1993
Designed in the UKWe make sure we execute the perfect hardware specification, firmware, connectivity platform and device lifecycle guarantee, which is purpose-built for global eCOA, ePRO and decentralised clinical trial deployment.
Latest hardware components selected guaranteeing supply for a minimum of 7 years.
Current-generation Android 16, with updates managed via FOTA on your schedule. With added security and identity checks, AI integration options, MDM provisioning improvements, and live notification reminders.
Full global type approvals and regulatory clearance certification making delivery easy. Ongoing recertification tracked and executed.
Your choice of Physical or eSIM, 4G/5G, and covering 200+ countries via 500+ carriers via the STK Nexus™ connectivity platform.
Android Enterprise Recommended and Google Mobile Services certified. We guarantee our devices are Google compliant, 100% secure, zero touch and Android update ready.
Why stock 6 different device chargers when you can stock 1? Our single SKU global charging unit, reduces inventory and complexity, and is certified in every country.
On-device inference for biometric identity, multilingual ePRO engagement and passive signal capture | privacy-preserving by design.
Industry-leading 5 year device warranty, with our no quibble instant replacement policy. Protecting study continuity whilst enhancing your cost savings.
Localised on device language integration, designed for global patient support.
Group owned dedicated UK based device refurbishment and disposal business, with full ISO 14001 accreditation.
STK Helix comes with an easily accessible replaceable battery, ensuring devices stay working all day in the field, keeping trials online and moving forward.
30,000 sq. ft. UK warehouse and distribution hub, supported by regional fulfilment hubs across Europe, China and the Middle East. Enabling scalable device storage, configuration, kitting and rapid deployment to clinical trial sites worldwide.